Direct lenders back Worldwide Clinical buyout at mid-6x leverage

Share

News and Analysis

Direct lenders back Worldwide Clinical buyout at mid-6x leverage

David Brooke's avatar
Will Caiger-Smith's avatar
  1. David Brooke
  2. +Will Caiger-Smith
2 min read

Kohlberg & Company has inked a deal to acquire pharmaceutical research provider Worldwide Clinical Trials at a roughly $2bn valuation, with debt financing from a group of direct lenders led by Blue Owl, according to 9fin sources.

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by 9 of the top 10 Investment Banks

Cookies & Privacy

We would like to use cookies to improve our service. Is that ok?